Small Lymphocytic Leukemia

• CLINICAL_TRIALS research · 2026-03-27
  Clinical Trial Update: Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) [Phase 2]

  A Phase II clinical trial is investigating a triplet regimen of zanubrutinib, obinutuzumab, and venetoclax in patients with chronic lymphocy…

• CLINICAL_TRIALS research · 2026-01-07
  Clinical Trial Update: Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL [Phase 3]

  A Phase 3 trial is evaluating adding Sonrotoclax to Zanubrutinib for patients with previously untreated chronic lymphocytic leukemia or smal…

• CLINICAL_TRIALS trial_result · 2025-12-03
  Clinical Trial Update: REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

  This clinical trial update reports on refractoriness to ibrutinib, a Bruton Tyrosine Kinase inhibitor, and to systemic targeted therapies in…

• CLINICAL_TRIALS trial_result · 2025-09-02
  Clinical Trial Update: Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) [Phase 2]

  Phase 2 study evaluating ibrutinib as early therapy for chronic lymphocytic leukemia and small lymphocytic leukemia; the trial is completed …

• CLINICAL_TRIALS trial_result · 2022-08-18
  Clinical Trial Update: Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL [Phase 1, Phase 2]

  Phase 1/2 trial of MT-3724 in relapsed or refractory diffuse large B-cell lymphoma and related B-cell hematologic malignancies; the study is…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-03-09
  Clinical Trial Update: Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]

  Phase 2 trial of duvelisib in ibrutinib-resistant CLL/SLL was terminated; results posted in 2022.

• CLINICAL_TRIALS trial_result · 2017-04-12
  Clinical Trial Update: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia [Phase 1]

  A Phase I dose-escalation study of CAT-8015 (moxetumomab pasudotox) in participants with chronic leukemia; the trial was terminated and resu…

• CLINICAL_TRIALS trial_result · 2016-05-27
  Clinical Trial Update: Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL [Phase 1]

  A Phase 1 dose-escalation study of lenalidomide (Revlimid) with fludarabine-rituximab in patients with chronic lymphocytic leukemia and smal…

• CLINICAL_TRIALS research · 2007-05-07
  Clinical Trial Update: Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia [Phase 1, Phase 2]

  This clinical trial update covers a Phase 1/2 study of AQ4N in patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small …